Alkermes Investigational Site

Tucson, Arizona 85719

0 studies enrolling now · 9 studies all time

What they study most

Alcohol Dependence, Major Depressive Disorder, Multiple Sclerosis, Refractory Major Depressive Disorder, Relapsing Remitting Multiple Sclerosis, Schizophrenia

Studies at this site

• Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS) — Completed
• A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1 — Completed
• A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD) — Stopped early
• A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD) — Completed
• A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2 — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study — Completed
• A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD) — Completed
• A Long-Term Safety Study of ALKS 5461 — Completed
• ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence — Completed